臨床應(yīng)用
● 用于原發(fā)性肝細(xì)胞肝癌高危人群及疑似患者的入院輔助檢查。
● 用于原發(fā)性肝細(xì)胞肝癌確診患者治療過(guò)程中的動(dòng)態(tài)監(jiān)測(cè), 以輔助判治療效果。
● 用于原發(fā)性肝細(xì)胞肝癌治療后的定期復(fù)查,以輔助判斷疾病進(jìn)程與監(jiān)測(cè)復(fù)發(fā)。
● It is used for the auxiliary examination of high-risk subjects and patients with hepatocellular carcinoma.
● It is used for dynamic monitoring of therapeutic efficiency during the treatment of patients diagnosed with hepatocellular carcinoma.
● It is used for regular detection after treatment of hepatocellular carcinoma to monitor the disease process and recurrence.